Ironwood Pharmaceuticals Raises FY2026 Sales Guidance from $460.000M-$485.000M to $485.000M-$510.000M vs $471.600M Est
Benzinga Newsdesk 2 hours ago
NewsGuidance
Ironwood Pharmaceuticals (NASDAQ:IRWD) raises FY2026 sales outlook from $460.000 million-$485.000 million to $485.000 million-$510.000 million vs $471.600 million estimate.
Ironwood Pharmaceuticals (NASDAQ:IRWD) raises FY2026 sales outlook from $460.000 million-$485.000 million to $485.000 million-$510.000 million vs $471.600 million estimate.